Prognosis for patients with unilateral Wilms' tumor in Rio de Janeiro, Brazil, 1990-2000

被引:5
作者
Grabois, MF
Azevedo, G
Mendonça, S
机构
[1] Hosp Canc 1, INCA, Serv Oncol Pediat, BR-20230130 Rio De Janeiro, RJ, Brazil
[2] Univ Estado Rio De Janeiro, Inst Social Med, Dept Epidemiol, Rio De Janeiro, RJ, Brazil
来源
REVISTA DE SAUDE PUBLICA | 2005年 / 39卷 / 05期
关键词
Wilms tumor; nephroblastoma; diagnosis; pathology; prognosis; anaplasia; survival analysis;
D O I
10.1590/S0034-89102005000500006
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective To analyze the survival and the main prognostic factors among patients with unilateral Wilms' tumor patients. Methods The study cohort included 132 patients with unilateral Wilms' tumor aged under 15 years, who were enrolled in a pediatric oncology service. Survival curves were calculated using the Kaplan-Meier method and the prognostic factors were analyzed using the Cox proportional hazards model. Results The overall survival rate for five years was 84.6%. The survival probabilities for disease in stages I, II, III and IV stages were: 100%, 94.2%, 83.2% and 31.3%, respectively. The survival rate was 89.4% for patients with favorable histology: 66.7% for focal anaplasia and 40% for diffuse anaplasia. All patients with stage IV disease and diffuse anaplasia died (n = 4). All patients with stage I disease, regardless of histology, remained alive at the end of the follow-up period. Conclusions Among the variables selected for the final model, only the staging and the histology remained associated with high risk of death risk, while patients aged 24-47 months presented better prognosis than the other patients. These results showed the importance of establishing the diagnosis at an early stage, and that the histology is fundamental for guiding the appropriate therapy.
引用
收藏
页码:731 / 737
页数:7
相关论文
共 21 条
[1]  
Beckwith J. Bruce, 1994, P1741
[2]   Revised SIOP working classification of renal tumors of childhood [J].
Beckwith, JB .
MEDICAL AND PEDIATRIC ONCOLOGY, 2002, 38 (02) :77-78
[3]  
Boccon-Gibod L, 2000, MED PEDIATR ONCOL, V34, P183, DOI 10.1002/(SICI)1096-911X(200003)34:3<183::AID-MPO4>3.0.CO
[4]  
2-O
[5]  
BRESLOW N, 1991, CANCER-AM CANCER SOC, V68, P2345, DOI 10.1002/1097-0142(19911201)68:11<2345::AID-CNCR2820681103>3.0.CO
[6]  
2-T
[7]  
CHOW WH, 1996, CANC EPIDEMIOLOGY PR, P1331
[8]  
Cleves M.A., 2002, INTRO SURVIVAL ANAL
[9]  
DANGIO GJ, 1989, CANCER-AM CANCER SOC, V64, P349, DOI 10.1002/1097-0142(19890715)64:2<349::AID-CNCR2820640202>3.0.CO
[10]  
2-Q